购物车
- 全部删除
- 您的购物车当前为空
RGH-5526是一种新型的抗高血压药。它引起下丘脑去甲肾上腺素(NA)周转(利用)增加,下丘脑去甲肾上腺素能神经元活性的增加可能导致外周交感神经活性的降低,从而显著降低血压。
RGH-5526是一种新型的抗高血压药。它引起下丘脑去甲肾上腺素(NA)周转(利用)增加,下丘脑去甲肾上腺素能神经元活性的增加可能导致外周交感神经活性的降低,从而显著降低血压。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
25 mg | ¥ 10,600 | 6-8周 | |
50 mg | ¥ 13,800 | 6-8周 | |
100 mg | ¥ 17,500 | 6-8周 |
产品描述 | RGH-5526 is a novel antihypertensive drug. It causes an increase in hypothalamic norepinephrine (NA) turnover (utilization), and the increase in hypothalamic noradrenergic neuron activity may lead to a decrease in peripheral sympathetic nerve activity, resulting in a significant reduction in blood pressure. |
体内活性 | Following prolonged treatment, RGH-5526 does not influence the hypothalamic monoamine oxidase (MAO)-activity. Results show a sharp (61%) decrease the hypothalamic Noradrenaline (NA) level 2 h after the administration of 10 mg/kg of RGH-5526, and this effect lasts for 4 to 6 h. It is shown that RGH-5526 exerts a greater NA lowering effect in the hypothalamus than in the periphery[1]. |
别名 | GYKI-11679 |
分子量 | 335.4 |
分子式 | C16H25N5O3 |
CAS No. | 69579-13-1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.